کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8666103 | 1576885 | 2018 | 39 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Evidence Review CommitteeTargets - اهدافcardiovascular disease - بیماری قلب و عروقیACC/AHA Clinical Practice Guidelines - دستورالعمل تمرینات بالینی ACC / AHAMeta-analysis - فرا تحلیل Hypertension - فشار خون بالاBlood pressure - فشارخونTreatment outcomes - نتایج درمانhome blood pressure monitoring - نظارت بر فشار خون خانگی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Our results suggest that: 1) There is a modest but significant improvement in systolic BP in randomized controlled trials of self-measured BP versus usual care at 6 but not 12 months, and for selected patients and their providers self-measured BP may be a helpful adjunct to routine office care. 2) systolic BP lowering to a target of <130 mm Hg may reduce the risk of several important outcomes including risk of myocardial infarction, stroke, heart failure, and major cardiovascular events. No class of medications (i.e., angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, calcium channel blockers, or beta blockers) was significantly better than thiazides and thiazide-like diuretics as a first-line therapy for any outcome.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of the American College of Cardiology - Volume 71, Issue 19, 15 May 2018, Pages 2176-2198
Journal: Journal of the American College of Cardiology - Volume 71, Issue 19, 15 May 2018, Pages 2176-2198
نویسندگان
David M. (Chair, Evidence Review Committee), Norrina B. (Evidence Review Committee Member), Michael E. (Evidence Review Committee Member), Eliseo (Evidence Review Committee Member), Yuling (Evidence Review Committee Member),